Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.63 - $2.96 $35,281 - $165,768
-56,003 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.43 - $3.14 $5,637 - $12,377
-3,942 Reduced 6.58%
56,003 $113,000
Q4 2021

Feb 11, 2022

SELL
$2.7 - $4.76 $4,843 - $8,539
-1,794 Reduced 2.91%
59,945 $162,000
Q3 2021

Nov 12, 2021

BUY
$4.06 - $5.8 $24,047 - $34,353
5,923 Added 10.61%
61,739 $275,000
Q2 2021

Aug 13, 2021

BUY
$5.02 - $7.05 $37,554 - $52,741
7,481 Added 15.48%
55,816 $324,000
Q1 2021

May 07, 2021

BUY
$4.81 - $10.34 $615 - $1,323
128 Added 0.27%
48,335 $339,000
Q4 2020

Feb 12, 2021

SELL
$4.13 - $6.41 $5,715 - $8,871
-1,384 Reduced 2.79%
48,207 $231,000
Q3 2020

Nov 04, 2020

BUY
$4.82 - $7.72 $25,893 - $41,471
5,372 Added 12.15%
49,591 $289,000
Q2 2020

Aug 12, 2020

BUY
$5.69 - $9.69 $82,021 - $139,681
14,415 Added 48.37%
44,219 $298,000
Q1 2020

May 04, 2020

SELL
$3.77 - $11.0 $6,499 - $18,964
-1,724 Reduced 5.47%
29,804 $190,000
Q4 2019

Feb 05, 2020

SELL
$3.0 - $16.43 $792 - $4,337
-264 Reduced 0.83%
31,528 $329,000
Q3 2019

Nov 08, 2019

BUY
$3.93 - $15.35 $2,931 - $11,451
746 Added 2.4%
31,792 $125,000
Q2 2019

Aug 13, 2019

BUY
$12.81 - $25.67 $8,762 - $17,558
684 Added 2.25%
31,046 $462,000
Q1 2019

May 06, 2019

SELL
$17.66 - $30.28 $17,377 - $29,795
-984 Reduced 3.14%
30,362 $754,000
Q4 2018

Feb 13, 2019

SELL
$11.63 - $32.67 $2,802 - $7,873
-241 Reduced 0.76%
31,346 $563,000
Q3 2018

Nov 09, 2018

BUY
$29.37 - $49.48 $16,711 - $28,154
569 Added 1.83%
31,587 $928,000
Q2 2018

Aug 08, 2018

BUY
$42.06 - $62.4 $123,151 - $182,707
2,928 Added 10.42%
31,018 $1.41 Million
Q1 2018

May 07, 2018

SELL
$50.12 - $67.72 $75,681 - $102,257
-1,510 Reduced 5.1%
28,090 $1.48 Million
Q4 2017

Feb 09, 2018

BUY
$57.69 - $84.58 $32,075 - $47,026
556 Added 1.91%
29,600 $2.01 Million
Q3 2017

Nov 09, 2017

BUY
$67.17 - $84.81 $1.95 Million - $2.46 Million
29,044
29,044 $2.39 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.